文献速递乳腺乳腺X线US

结合乳腺X线腋尾位置的模型用于初始cN+乳腺癌新辅助化疗后前哨淋巴结阴性患者非前哨淋巴结转移的术前预测

A Model Incorporating Axillary Tail Position on Mammography for Preoperative Prediction of Non-sentinel Lymph Node Metastasis in Patients with Initial cN+ Breast Cancer after Neoadjuvant Chemotherapy.
PubMed 文献 · Acad Radiol · 2022-04-30

本研究回顾257例初始cN+乳腺癌患者,均在新辅助化疗后行前哨淋巴结活检及腋窝淋巴结清扫,基于临床因素及化疗后乳腺X线腋尾位置和腋窝超声构建预测非前哨淋巴结转移的模型。临床模型训练集AUC 0.82、验证集0.83,加入影像因素后临床影像模型训练集AUC 0.87、验证集0.89。作者认为该模型表现优异,可帮助筛选新辅助化疗后可避免不必要腋窝淋巴结清扫的患者。

要点

  • 新辅助化疗后乳腺X线腋尾位置与腋窝超声联合临床因素可预测非前哨淋巴结转移。
  • 临床影像模型训练集AUC 0.87(95%CI 0.81-0.93),验证集AUC 0.89(95%CI 0.82-0.96)。
  • 作者认为该模型可帮助筛选新辅助化疗后可避免不必要腋窝淋巴结清扫的患者。

核心结论

  • 将新辅助化疗后乳腺X线腋尾位置和腋窝超声结果与其他临床因素结合构建的模型,可在术前预测初始cN+患者的非前哨淋巴结转移,模型表现优异,作者认为可帮助医生筛选新辅助化疗后可避免不必要腋窝淋巴结清扫的患者。

研究设计与样本

  • 回顾性研究,共纳入257例初始cN+乳腺癌患者,均在新辅助化疗后行前哨淋巴结活检和腋窝淋巴结清扫;基于单因素分析中p<0.1的四个临床因素及新辅助化疗后乳腺X线腋尾位置和腋窝超声结果构建逻辑回归模型。

关键影像表现/征象

  • 新辅助化疗后乳腺X线腋尾位置和腋窝超声结果被加入临床模型,用于构建预测非前哨淋巴结转移的临床影像模型。

诊断标准与关键数值

  • 临床模型(基于ycT0、新辅助化疗前临床分期、雌激素受体表达、HER2状态四个因素)训练集AUC 0.82(95%CI 0.76-0.88),验证集AUC 0.83(95%CI 0.74-0.92)。
  • 临床影像模型(临床模型加新辅助化疗后腋窝超声和乳腺X线腋尾位置)训练集AUC 0.87(95%CI 0.81-0.93),验证集AUC 0.89(95%CI 0.82-0.96)。

临床应用与阅片要点

  • 作者认为该模型可帮助医生筛选新辅助化疗后可避免不必要腋窝淋巴结清扫的患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: This study aimed to develop a model incorporating axillary tail position on mammography (AT) for the prediction of non-sentinel Lymph Node (NSLN) metastasis in patients with initial clinical node positivity (cN+).

METHODS AND MATERIALS: The study reviewed a total of 257 patients with cN+ breast cancer who underwent both sentinel lymph node biopsy (SLNB) and axillary lymph node dissection (ALND) following neoadjuvant chemotherapy (NAC). A logistic regression model was developed based on these factors and the results of post-NAC AT and axillary ultrasound (AUS).

RESULTS: Four clinical factors with p<0.1 in the univariate analysis, including ycT0(odds ratio [OR]: 4.84, 95% confidence interval [CI]: 2.13-11.91, p<0.001), clinical stage before NAC (OR: 2.68, 95%CI: 1.15-6.58, p=0.025), estrogen receptor (ER) expression (OR: 3.29, 95%CI: 1.39-8.39, p=0.009), and HER2 status (OR: 0.21, 95%CI: 0.08-0.50, p=0.001), were independent predictors of NSLN metastases. The clinical model based on the above four factors resulted in the area under the curve (AUC) of 0.82(95%CI: 0.76-0.88) in the training set and 0.83(95% CI: 0.74-0.92) in the validation set. The results of post-NAC AUS and AT were added to the clinical model to construct a clinical imaging model for the prediction of NSLN metastasis with AUC of 0.87(95%CI: 0.81-0.93) in the training set and 0.89(95%CI: 0.82-0.96) in the validation set.

CONCLUSIONS: The study incorporated the results of post-NAC AT and AUS with other clinal factors to develop a model to predict NSLN metastasis in patients with initial cN+ before surgery. This model performed excellently, allowing physicians to select patients for whom unnecessary ALND could be avoided after NAC.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Zhu, Lin, Zhang, et al. A Model Incorporating Axillary Tail Position on Mammography for Preoperative Prediction of Non-sentinel Lymph Node Metastasis in Patients with Initial cN+ Breast Cancer after Neoadjuvant Chemotherapy. Acad Radiol. 2022. PMID: 35504810. doi:10.1016/j.acra.2022.03.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。